Influence of Bence-Jones proteins, hyperviscosity, hypercalcemia, hyperuricemia and dehydration on development of renal changes in plasma cell dyscrasias
Lenert, P.; Drazen, F.; Tepavcević, P.; Pejin, D.; Curić, S.; Ilić, V.; Uzurov, V.; Popowić, S.; Zupunski, A.; Djisalov, M.
Przeglad Lekarski 42(4): 384-386
1985
ISSN/ISBN: 0033-2240 PMID: 4048525 Document Number: 243005
Document emailed within 1 workday
Related Documents
Togawa, A.; Imamura, Y. 1980: Study on the Bence Jones protein--molecular weight and polymeric forms of Bence Jones proteins Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 43(5): 850-855Deegan, M.J. 1976: Bence jones proteins: nature, metabolism, detection and significance Annals of Clinical and Laboratory Science 6(1): 38-46
Linke, R.P.; Tischendorf, F.W.; Zucker-Franklin, D.; Franklin, E.C. 1973: The formation of amyloid-like fibrils in vitro from Bence Jones Proteins of the Vlambdai subclass Journal of Immunology 111(1): 24-26
Caenazzo, A.; Sartori, D.; Poletti, A. 1997: Bence Jones myeloma with signet-ring-like plasma cells Haematologica 82(1): 122
Woodruff, R.; Sweet, B. 1977: Multiple myeloma with massive Bence Jones proteinuria and preservation of renal function Australian and New Zealand Journal of Medicine 7(1): 60-62
McLaughlin, C.L.; Solomon, A. 1971: Bence Jones proteins and light chains of immunoglobulins. VI. Immunochemical detection of interclass similarities among kappa-chains Journal of Immunology 107(6): 1699-1705
Karmakar, T.; Datta, U.; Varma, S.; Banerjee, C.K.; Sharma, S.; Sehgal, S. 1995: Paraproteins and plasma cell dyscrasias Indian Journal of Pathology and Microbiology 38(3): 239-243
Avisar, R.; Shoenfeld, Y.; Pick, A.I.; Creter, D.; Cohen, A.; Djaldetti, M.; Savir, H. 1981: Plasma cell dyscrasias. Part I: Fluorescein angiography findings Metabolic and Pediatric Ophthalmology 5(3-4): 171-175
Geniram, A.; Fiorini, G.; Spotti, D.; Frezzini, G.; Guarino, P.; Venturino, M.; Marini, U. 1984: Benign and malignant plasma cell dyscrasias: methods of study Haematologica 69(2): 163-177
Eichner, E.R. 1980: The plasma cell dyscrasias: diverse presentations, pathophysiology, and management Postgraduate Medicine 67(6): 44-9 53-4 57-8 Passim
Greco, C.; Alvino, S.; Del Monte, G.; Venturo, I.; Lopez, M. 2003: Potential usefulness of serum p53 for laboratory management of plasma cell dyscrasias Journal of Experimental and Clinical Cancer Research: Cr 22(4): 607-612
Sawkar, L.A. 1972: Hyperviscosity syndrome in acute plasma cell leukaemia Journal of the Association of Physicians of India 20(5): 397-402
Taylor, D.G. 1974: Bence Jones proteinuria Journal of the Tennessee Medical Association 67(5): 409
Rebollar, J.L.; Villegas, A.; Martinez, E.; Gilsanz, V. 1976: Bence-Jones' myeloma Revista Clinica Espanola 143(1): 45-51
Strada, E.; Battistelli, L.; Savazzi, G. 2008: Bence-Jones proteinuria and kidney's damages Recenti Progressi in Medicina 99(7-8): 389-394
Juncà Piera, J.; Casals Pascual, A.; Formiguera Sala, X.; Millà Santos, F.; Flores López, A.; Rey-Joly Barroso, C. 1987: Bence Jones proteinuria 6 years in developing Medicina Clinica 88(9): 378-380
Perry, M.C.; Kyle, R.A. 1975: The clinical significance of Bence Jones proteinuria Mayo Clinic Proceedings 50(5): 234-238
Liu, J.H.; Malone, R.S.; Stallings, H.; Smith, P.C. 1996: Influence of renal failure in rats on the disposition of salicyl acyl glucuronide and covalent binding of salicylate to plasma proteins Journal of Pharmacology and Experimental Therapeutics 278(1): 277-283
Trizio, D.; Ferrannini, A. 1970: Chromosome studies in a case of Bence Jones myeloma Haematologica 55(12): 774-777
Mafune, N.; Kobayashi, K. 1999: Bence Jones protein--detection and clinical aspects Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 106-109